(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of 5.4% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.6%.
Iridex's revenue in 2026 is $51,573,000.On average, 3 Wall Street analysts forecast IRIX's revenue for 2026 to be $940,969,901, with the lowest IRIX revenue forecast at $904,083,586, and the highest IRIX revenue forecast at $968,652,202. On average, 3 Wall Street analysts forecast IRIX's revenue for 2027 to be $1,002,903,780, with the lowest IRIX revenue forecast at $963,558,378, and the highest IRIX revenue forecast at $1,032,395,268.
In 2028, IRIX is forecast to generate $1,075,113,134 in revenue, with the lowest revenue forecast at $1,032,957,345 and the highest revenue forecast at $1,106,729,975.